To provide a sustainable level of income and the prospect of capital growth over the long term.
Name | % Net Assets |
---|---|
AstraZeneca | 3.2% |
Centrica | 2.1% |
France Telecom 7.25% 10/11/20 | 2.0% |
British Telecom 7.5% VRN 07/12/16 | 2.0% |
GlaxoSmithKline | 2.0% |
Hutchison Ports Finance 6.75% 07/12/15 | 2.0% |
BP | 1.9% |
Roche Finance Europe 5.375% 29/08/23 | 1.9% |
Vodafone | 1.9% |
Tesco 5.5% 13/12/19 | 1.8% |
Key | % Net Assets |
---|---|
AstraZeneca | 3.2% |
Centrica | 2.1% |
France Telecom 7.25% 10/11/20 | 2.0% |
British Telecom 7.5% VRN 07/12/16 | 2.0% |
Other | 90.7% |
Date | 21-Nov-2024 |
---|---|
NAV | 52.03p |
Currency | GBP |
Change | -0.030p |
% | -0.06% |
YTD change | 0.68p |
YTD % | 1.32% |
Fund Inception | 04/03/2002 |
---|---|
Fund Manager | n/a |
TER | 1.39 (31-Oct-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | £100 |
Charges | |
---|---|
Initial | 4.50% |
Annual Mang't | 1.25% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.13 |
You are here: research